Design for a Phase 1b study evaluating the safety and tolerability of a 4-week continuous subcutaneous infusion of ABBV-951 in Parkinson's disease patients M. Facheris,C. Locke,X. Qi,W. Robieson, M. Rosebraugh,J. BeneshEUROPEAN JOURNAL OF NEUROLOGY（2019）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
